Anexă din 8 noiembrie 2010

93. Merkus MP, Jager KJ, Dekker FW, de Haan RJ, Boeschoten EW, Krediet RT. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis. 2000 Jan;35(1):69-79

94. Royal College of Physicians. Renal Association. Joint Specialty Committee for Renal Disease. Meeting held on Thursday, 16 June 2005, 15.00 Hrs, at the College. Minutes

95. United States Department of Veterans Affairs. VA Sunshine Healthcare Network.Pszchology Program. http://www.visn8.med.va.gov/visn8/tampa/education/psychologyip/rotations.asp

96. Oberley ET, Sadler JH, et al. Renal rehabilitation: obstacles, progess and prospects for the future. Am J Kidney Dis 2000; 35:141-147

97. Blake C, Plant WD. Measures to improve quality of life in end-stage renal disease patients. In: Therapy in Nephrology and Hypertension, Brady HR, Wilcox CS eds. Sounders 2003; pp. 747-751

98. Painter P, Steward AL, Carey S. Physical functioning: Definitions, measurement and expectations. Adv Ren Replace Ther 1999; 6:110-123

99. Painter P. The importance of exercise training in rehabilitation of patients with end-stage renal disease. Am J Kidney Dis 1994; 24:S2-S9

100. Ifudu O, Paul H, Mayers J, et al. Pervasive failed rehabilitation in center-based maintenance hemodialysis patients. Am J Kidney Dis 1994; 23:394-400

101. Avram MM, Sreehara R, Mittiman N. Long-term survival in end-stage renal disease. Dial Transplant 1998; 27:11-21

102. Ifudu O, Matthew J, Tan CC. Dismal rehabilitation in geriatric inner-city hemodialysis patients. JAMA 1994; 27:29-33

103. Deligiannis A, Koudi E, Tourkantonis A. Effects of physical training on heart rate variability in patients on hemodialysis. Am J Cardiol 1999; 84:197-202

104. Lundin AP, Akerman MJ, Chesler RM, et al. Exercise in hemodialysis patients after treatment with recombinant human erythropoietin. Nephron 1991; 58:315-319

105. Moore GE, Parsons DB, Stray-Gundersen J, et al. Uremic myopathy limits aerobic capacity in hemodialysis patients. Am J Kidney Dis 1993; 22:277-287

106. Kouidi E, Albani M, Natsis K, et al. The effects of exercise training on muscle atrophy in hemodialysis patients. Nephrol Dial Transplant 1998; 13:685-699

107. Surgeon General's Report on physical activity and health. From the Centers for Disease Control and Prevention. JAMA 1996; 276:522

108. Sietsema KE, Amato A, Adler SG, Brass EP: Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 65:719-724, 2004

109. O'Hare AM, Tawney K, Bacchetti P, Johansen KL. Decreased survival among sedentary patients undergoing dialysis: Results from the Dialysis Morbidity and Mortality Study Wave 2. Am J Kidney Dis 2003; 41:447-454

110. Johansen KL. Physical functioning and exercise capacity in patients on dialysis. Adv Ren Replace Ther 1999; 6:141-148

111. 111.Shalom R, Blumenthal JA, Williams RS. Feasibility and benefits of exercise training in patients on meintenance dialysis. Kidney Int 1984; 25:958-963

112. DePaul V, Moreland J, Eager T, Clase CM. The effectiveness of aerobic and muscle strenght training in patients receiving hemodialysis and EPO: a randomized controlled trial. Am J Kidney Dis 2002; 40:1219-1229

113. Blair SN, Kohl HW, 3rd, Paffenbarger RS, Jr., Clark DG, Cooper KH, Gibbons LW: Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262:2395-2401, 1989

114. Wei M, Gibbons LW, Mitchell TL, Kampert JB, Lee CD, Blair SN: The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 130:89-96, 1999

115. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN: Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med 132:605-611, 2000

116. Blair SN, Goodyear NN, Gibbons LW, Cooper KH: Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA 252:487-490, 1984

117. Office of the U.S. Surgeon General, Physical Activity and Health: A Report of the Surgeon General, in, U.S. Department of Health and Human Services, Public Health Service, 1996

118. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. National Heart, Lung and Blood Institute: Bethesda. Bethesda, MD, NHLBI, 1997

119. National Cholesterol Education Project, Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adult (Adult Treatment Panel III), in, Bethesda, MD, NIH - NHLBI, 2000

120. http:/www.usrds.org/2001pdf/c.pdf. The USRDS Dialysis Morbidity and Mortality Study: Wave 2. US Renal Data System. Am J Kidney Dis 1997; 30:S67-85

121. Koniger M, Quaschning T, Wanner C, et al. Abnormalities in lipoprotein metabolism in hemodialysis patients. Kidney Int 1999; 71:S248-S250

122. Alabakovska SB, Todorova BB, Labudovic DD, Tosheska KN. LDL subclass distribution in patients with end-stage renal disease. Clin Biochem 2002; 35:211-216

123. Van Guldener C, Lambert J, Janssen MJ, et al. Endothelium-dependent vasodilatation and distensibility of large arteries in chronic hemodialysis patients. Nephrol Dial Transplant 1997; 12:S14-S18

124. Joannides R, Bakkali, Le Roy F, et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance hemodialysis. Nephrol Dial Transplant 1997; 12:2623-2628

125. Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16:1189-1197

126. Brendle DC, Joseph LJ, Corretti MC, et al. Effects of exercise rehabilitation on endothelial reactivity in older patients with periferal arterial disease. Am J Cardiol 2001; 87:324-329

127. Durstine JL, Haskell WL. Effects of exercise training on plasma lipids and lipoproteins. Exerc Sport Sci Rev 1994; 22:477-521

128. Green DJ, Cable NT, Fox C, et al. Modification of forearm resistance vessels by exercise training in young men. J Appl Physiol 1994; 77:1829-1833

129. Highashi Y, Sasaki S, Kurisu S, et al. Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects. Role of endothelium-derived nitric oxide. Circulation 1999; 100:1194-1202

130. Miller BW, Cress CL, Johnson ME, et al. Exercise during hemodialysis decreases the use of antihypertensive medications. Am J Kidney Dis 2002; 39:828-833

131. Goldberg AP, Hagberg JM, Delmez JA, Heath GW, Harter HR: Exercise training improves abnormal lipid and carbohydrate metabolism in hemodialysis patients. Trans Am Soc Artif Intern Organs 25:431-437, 1979

132. Deligiannis A, Kouidi E, Tassoulas E, Gigis P, Tourkantonis A, Coats A: Cardiac effects of exercise rehabilitation in hemodialysis patients. Int J Cardiol 70:253-266, 1999

133. Hagberg JM, Goldberg AP, Ehsani AA, Heath GW, Delmez JA, Harter HR: Exercise training improves hypertension in hemodialysis patients. Am J Nephrol 3:209-212, 1983

134. Johansen KL, Chertow GM, Ng AV, Mulligan K, Carey S, Schoenfeld PY, Kent-Braun JA: Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int 57:2564-2570, 2000

135. Johansen KL, Kaysen GA, Young BS, Hung AM, da Silva M, Chertow GM: Longitudinal study of nutritional status, body composition, and physical function in hemodialysis patients. Am J Clin Nutr 77:842-846, 2003

136. Lo CY, Li L, Lo WK, Chan ML, So E, Tang S, Yuen MC, Cheng IK, Chan TM: Benefits of exercise training in patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 32:1011-1018, 1998

137. Painter P, Moore G, Carlson L, Paul S, Myll J, Phillips W, Haskell W: Effects of exercise training plus normalization of hematocrit on exercise capacity and healthrelated quality of life. Am J Kidney Dis 39:257-265, 2002

138. Akiba T, Matsui N, Shinohara S, Fujiwara H, Nomura T, Marumo F: Effects of recombinant human erythropoietin and exercise training on exercise capacity in hemodialysis patients. Artif Organs 19:1262-1268, 1995

139. Christensen AJ, Smith TW, Turner CW, et al. Family support, physical impairment and adherence in hemodialysis: An investigation of main and buffering effects. J Behav Med 1992; 15:313-325

140. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988; 24:540-545

141. Kimmel PL, Peterson RA, Weihs KL, et al. Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int 1998; 54:245-254

142. Uchino BN, Caccioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health. Psychol Bull 1996; 191:488-531

143. McClellan WM, Anson C, Birkeli K, et al. Functional status and quality of life: predictors of early mortality among patients entering treatment for end-stage renal disease. J Clin Epidemiol 1991; 44: 83-89

144. McClellan WM, Stanwyck DJ, Anson CA. Social support and subsequent mortality among patients with end-stage renal disease. J Am Soc Nephrol 1993; 4:1028-1034

145. Leggat JE, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis 1998; 32:139-145

146. Reiss D, Gonzalez S, Kramer N. Family processes, chronic illness and death: on the weakness of strong bonds. Arch Gen Psychiatry 1986; 43:795-804

147. Kaveh K, Kimmel PL. Compliance in hemodialysis patients: multidimensional measures in search of a gold standard. Am J Kidney Dis 2001; 36:244-266

148. Kimmel PL, Peterson RA, Weihs KL, et al. Psychologic functioning, quality of life and behavioral compliance in patients beginning hemodialysis. J Am Soc Nephrol 1996; 7:2152-2159

149. Saran R, Bragg-Gresham J, Rayner H, et al. Nonadherence in hemodialysls: association with mortality, hospitalization and practice patterns in the DOPPS. Kidney Int 2003; 64: 254-262

150. Kimmel PL, Paterson RA, Weihs KL, et al. Dyadic relationship conflict, gender and mortality in urban hemodyalisis patients. J Am Soc Nephrol 2000; 11:1518-1525

151. Finkelstein FO, Finkelstein SH, Steele TE. Assessment of marital relationships in hemodyalisis patients. Am J Med Sci 1976; 271:21-28

152. Kiecolt-Glaser JK, Newton T, Cacioppo JT, MacCallum RC, Glaser R, Malarkey WB.. Marital conflict and endocrine function: are men really more physiologically affected than women? J Consult Clin Psychol 1996; 64:324-332

153. Turner-Musa J, Leidner D, Simmens S, et al. Family structure and patient survival in an African-American end-stage renal disease population: a preliminary investigation. Soc Sci Med 1999; 48: 1333-1340

154. McEwen B. Protecting and damaging effects of mediators of stress: elaborating and testing the concepts of allostasis and allostatic load. NY Acad Sci 1999; 896:30-47

155. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999 Feb;55(2):648-58

156. Foley RN, Herzog CA, Collins AJ. Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study. Kidney Int. 2003 Apr;63(4):1462-7.

157. Kestenbaum B, Gillen DL, Sherrard DJ, Seliger S, Ball A, Stehman-Breen C. Calcium channel blocker use and mortality among patients with end-stage renal disease. Kidney Int. 2002 Jun;61(6):2157-64.

158. Bloembergen WE, Port FK, Mauger EA, Briggs JP, Leichtman AB. Gender discrepancies in living related renal transplant donors and recipients. J Am Soc Nephrol. 1996 Aug;7(8):1139-44.

159. Tepel M, Giet MV, Park A, Zidek W. Association of calcium channel blockers and mortality in haemodialysis patients. Clin Sci (Lond). 2002 Nov;103(5):511-5.

160. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK. Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis. 1996 May;27(5):668-72.

161. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998 Sep;32(3):570-4.

162. Fleischmann EH, Bower JD, Salahudeen AK. Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients? Clin Nephrol. 2001 Sep;56(3):221-30.

163. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, Cataliotti A, Bellanuova I, Malatino LS, Soldarini A; CREED Investigators. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int. 2002 Feb;61(2):609-14.

164. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001 Nov;12(11):2458-64.

165. Kutner NG. Improving compliance in dialysis patients: Does anything work? Semin Dial, 2001; 14:324-327

166. Curtin RB, Oberley E, Sacksteder P. Compliance and rehabilitation in ESRD patients. Semin Dial 1997; 10:52-54

167. Wolcott DL, Maida CA, Diamond R, Nissenson AR. Treatment compliance in end-stage renal disease patients on dialysis. Am J Nephrol 1986; 6:329-338

168. Bame S, Petersen N, Wray N. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med 1993; 37:1035-1043

169. Sackett DL, Snow JC. The magnitude of compliance and noncompliance. In Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: John Hopkins university press, 1979; pp. 11-22

170. Nichols-English G, Poirier S. Optimizing adherence to pharmaceutical care plans. J Am Pharm Assoc 2000; 40:475-485

171. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50:550-556

172. Ifudu O, Henry P, Friedman EA. Effect of missed hemodialysis treatment(s) on mortality in patients with end-stage renal disease. Nephron 1998;79:385-386

173. Chisholm MA. Enhancing transplant patients' adherence to medication therapy. Clin Transplant 2002; 16:30-38

174. Leventhal H, Nerenz D, Steele D: Illness representations and coping withhealth threats, in:A handbook of psychology and health, Baum A, Singer J. vol IV, Hillsdale, NJ: Erlbaum, 1984, 219-252

175. Seica A, Covic A, Gusbeth-Tatomir P, Covic M. Rolul psihologului intr-un centru de dializa la nivelul anilor 2000. Adaptarea pacientilor dializati la boala cronica, calitatea vietii, programe de reabilitare. Nefrologia, 2001; 17:381-388

176. Baumann LJ, Cameron LD, Zimmerman RS, Leventhal H. Illness representations and matching labels with symptoms. Health Psychology, 1989;8:449-469

177. Bishop GD. Lay conceptions of physical symptoms. Journal of applied Social Psychology, 1987; 17:127-146

178. Lau RR, Bernard TM, Hartman KA. Further explorations of common-sense representations of common illnesses. Health Psycchology, 1989; 8:195-219

179. Meyer D, Leventhal H. Commonsense-models of illness: the example of hypertension. Health Psychology, 1985; 4:115-135

180. Broadbent E, Petriea KJ, Maina J, Weinman J. The Brief Illness Perception Questionnaire. Journal of Psychosomatic Research 60 (2006) 631- 637

181. Seica A, Covic A, Gusbeth-Tatomir P, Covic M. Rolul reprezentarilor mentale ale bolii in non-complianta pacientilor dializati la restrictia hidro-salina. Nefrologia 2002; 17:83-88

182. Sharp J, Wild M, Gumley AI. A systematic review of psychological interventions for the treatment of nonadherence to fluid intake restrictions in people receiving hemodialysis. Am J Kidney Dis 2005; 1:15-27

183. Lin CC, Liang CCA. The relationship between health locus of control and compliance of hemodialysis patients. Kao Hsiung I Hsueh Tsa Chih 1997; 13: 243-254

184. White CA. General components of CBT for chronic medical problems, in White CA: Cognitive Behavioral Therapy for Chronic Medical Problems: A Guide to Assessment and Treatment in Practice. New York, Wiley, 2001, pp. 3-13

185. Holdevici I. Ameliorarea performantelor individuale prin tehnici de psihoterapie. Ed. Orizonturi 2000

186. Sharp J, Wild MR, Gumley AI, Deighan CJ. A cognitive behavioral group approach to enhance adherence to hemodialysis fluid restrictions: A randomized controlled trial. Am J Kidney Dis 2005; 6: 1046-1057

187. Rozanski A, Blumenthal JA, Kaplan J: Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 99:2192-2217, 1999

188. Hensie LE, Campbell RJ: Psychiatric Dictionary, Oxford University Press, 1970

189. Todaro JF, Shen BJ, Niaura R, Spiro A, Ward KD: Effect of negative emotions on frequency of coronary heart disease (The Normative Aging Study). Am J Cardiol 92: 901-906, 2003

190. Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Pyschiat 55:580-592, 1998

191. Sirois BC, Burg MM: Negative emotion and coronary heart disease: A review. Behav Modif 27 83-102, 2003

192. Joynt KE, Whellan DJ, O'Connor CM: Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 54:248-261, 2003

193. Medalie JH, Goldbourt U: Angina pectoris among 10,000 men. II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five year incidence study. Am J Med 60:910-921, 1976

194. Goldstein MG, Niaura R: Psychological factors affecting physical condition. Cardiovascular disease literature review. Part I: Coronary artery disease and sudden death. Psychosomatics 33:134-145, 1992

195. Kimmel PL, Weihs K, Peterson RA: Survival in hemodialysis patients: the role of depression. J Am Soc Nephrol 4:12-27, 1993

196. Benedict RH, Fishman I, McClellan MM, Bakshi R, Weinstock-Guttman B: Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Mult Scler 9:393-396, 2003

197. Hays RD, Kallich JD, Mapes DL, Coons SJ, Amin N, Carter WB, Kamberg C.(1997).Kidney Disease Quality of Life Short Form (KDQOL-SF(tm)), Version 1.3: A Manual for Use and Scoring. Santa Monica, CA: RAND, P-7994. http://gim.med.ucla.edu/kdqol/downloads/download.html

198. Annotated Bibliography of the WHO Quality of Life Assessment Instrument- WHOQOL. Geneva, Switzerland, Department of Mental Health, WHO, 1998

199. Alarcon RD, Jenkins CS, Heestand DE, Scott LK, Cantor L: The effectiveness of progressive relaxation in chronic hemodialysis patients. J Chronic Dis 35:797-802, 1982

200. Mayne TJ, Ambrose TK: Research review on anger in psychotherapy. J Clin Psychol 55:353-363, 1999

201. Matthews KA, Haynes SG: Type A behavior pattern and coronary disease risk. Update and critical evaluation. Am J Epidemiol 123:923-960, 1986

202. Suinn RM: The terrible twos-anger and anxiety. Hazardous to your health. Am Psychol 56:27-36, 2001

203. Kimmel PL: Depression as a mortality risk factor in hemodialysis patients. Int J Artif Organs 15:697-700, 1992

204. Driessen M, Balck F. Chronic renal failure: predictors of good adjustment to disease and treatment (German). Psychotherapie, Psychosomatik, Medizinische, Psychologie 1991, 41: 363

205. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of depression predict mortality in a longitudinal study of chronic hemodialysis outpatients. Kidney Int 2000; 57:2093-8

206. Kimmel PL. Psychosocial factors in adult end-stage renal disease patients treated with hemodialysis: correlates and outcomes. Am J Kidney Dis 2000; 35:S132-40

207. Steele TE, Baltimore D, Finkelstein SH, et al. Quality of life in peritoneal dialysis patients. J Nerv Ment Dis 1996; 184:368-374

208. Finkelstein FO, Finkelstein SH. Depression in chronic dialysis patients: assessment and treatment. Nephrol Dial Transplant 2000; 15:1911-1913

209. Neu S, Kjellstrand. Stopping long-term dialysis: An empirical study of withdrawal of life-supporting treatment. N Engl J Med 1986; 314:14-20

210. USRDS 1999: Annual Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, April 1999

211. Lopes AA, Bragg J, Young E, et al. Depression as a predictor of mortality and hospitalization among hemodialysis patients in the United States and Europe. Kidney Int 200; 62:199-207

212. Peterson RA, Kimmel PL, Sacks CR, et al. Depression, perception of illness and mortality in patients with end-stage renal disease. Int J Psychiatry Med 1991; 21:343-354

213. Watnick S, Kirwin P, Mahnensmith R, Concato J. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis 2003;41:105-110

214. Christensen AJ, Wiebe JS, Smith TW, et al. Predictors of survival among hemodialysis patients: Effects of perceived family support. Health Psychology 1994;13:521-525

215. Booth-Kewley S, Friedman HS: Psychological predictors of heart disease: a quantitative review. Psychological Bulletin 101:343-362, 1987

216. Strik JJ, Denollet J, Lousberg R, Honig A: Comparing symptoms of depression and anxiety as predictors of cardiac events and increased health care consumption after myocardial infarction. J Am Coll Cardiol 42:1801-1807, 2003

217. Russek LG, King SH, Russek SJ, Russek HI: The Harvard Mastery of Stress Study 35-year follow-up: prognostic significance of patterns of psychophysiological arousal and adaptation. Psychosom Med 52:271-285, 1990

218. Verrier RL, Mittelman MA: Cardiovascular consequences of anger and other stress states. Baillieres Clinical Neurology 6:245-259, 1997

219. Kutner NG, Fair PL, Kutner MH: Assessing depression and anxiety in chronic dialysis patients. J Psychosom Res 29:23-31, 1985

220. Livesley WJ: Symptoms of anxiety and depression in patients undergoing chronic haemodialysis. J Psychosom Res 26:581-584, 1982

221. Fava M, Serafini E, De Besi L, Adami A, Mastrogiacomo, I.: Hyperprolactinemia and psychological distress in women undergoing chronic hemodialysis. Psychother Psychosom 49:6-9, 1988

222. White Y, Grenyer BF: The biopsychosocial impact of end-stage renal disease: the experience of dialysis patients and their partners. J Adv Nurs 30:1312-1320, 1999

223. Sesso R, Yoshihiro MM: Time of diagnosis of chronic renal failure and assessment of quality of life in haemodialysis patients. Nephrol Dial Transplant 12:2111-2116, 1997

224. Schneider SM, Pouget I, Staccini P, Rampal P, Hebuterne X: Quality of life in long-term home enteral nutrition patients. Clin Nutr 19:23-28, 2000

225. Apostolou T, Gokal R. Quality of life after peritoneal dialysis. In: Textbook of Peritoneal Dialysis. Ed. a II-a, Great Britain: Kluwer Academic Publishers, 2000; pp. 709-735

226. Valderrabano F. Quality of life benefits of early anemia treatment. Nephrol Dial Transplant 2000; 15:23-28

227. Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M: The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 262:925-930, 1989

228. Rettig RA, Sadler JH, Meyer KB, Wasson JH, Parkerson GR Jr, Kantz B, Hays RD, Patrick DL: Assessing health and quality of life outcomes in dialysis: A report on an Institute of Medicine workshop. Am J Kidney Dis 30:140-155, 1997

229. NKF K/DOKI Guidelines. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Part 6.Association of level of gfr with complications in adults. Guideline 12. Association of level of gfr with indices of functioning and well-being.

230. Kutner NG, Cardenas DD, Bower JD: Rehabilitation, aging and chronic renal disease. Am J Phys Med Rehabil 71:97-101, 1992